Epstein Secrets

From: jeffrey E. <[email protected]> Sent: Wednesday, December 7, 2016 5:26 PM To: Donald Rubin Subject: Re: Placebo effects, EB, etc. ar you around on the w

change- =ewline"> I'm always interested in unique idea EFTA_R1_01919683 EFTA02667790 On Wed, Dec 7, 2016 at 10:12 AM D=nald Rubin wrote: Hello Jeffrey, I'm glad that Martin has put us in touch for a couple of r=asons. First, I think we have some mutual interests concerning the c=mplications of doi

the use of the addressee. It is the proper=y of JE= Unauth=rized use, disclosure or copying of this

ner — under Bush II — was a pa=tial PhD student of mine when he was getting his MD at Harvard and his PhD=in Econ at MIT, and remains a good friend: Mark McClellen, who is interest=d in this stuff and remains quite influential in DC, I think). But the reas=n for rambling about the FDA and placebo effects is th

, will know tomrow. let you know. On Wed, Dec 7, 2016 at 1:47 PM, Donald Rubin • wrote: Think so. Where will you be? On Dec 7, 2016, at 12:25 PM, Jeffrey E. <[email protected]> wrote: ar you around on the weekend in cambridge.? On Wed, Dec 7, 2016 at 1:10 PM, Donald Rubin < wrote: OK. I'll get back t

AM, jeffrey E. <[email protected]> wrote: I'm always interested in unique idea On Wed, Dec 7, 2016 at 10:12 AM Donald Rubin < > wrote: Hello Jeffrey, I'm glad that Martin has put us in touch for a couple of reasons. First, I think we have some mutual interests concerning the complications of doi

er — under Bush II — was a partial PhD student of mine when he was getting his MD at Harvard and his PhD in Econ at MIT, and remains a good friend: Mark McClellen, who is interested in this stuff and remains quite influential in DC, I think). But the reason for rambling about the FDA and placebo effects is th

John L. Loeb Professor of Statistics Department =f Statistics, Harvard University 1 Oxford Street Cambridge MA 02138 On Dec 2, 2016, at 9:41 AM, jeffrey E. <[email protected]> wrote: great EFTA_R1_00109276 EFTA01786441 On Fri, Dec 2, 2016 at 9:40 AM, =onald Rubin wrote: Great, thanks Martin. Som

week is pretty much shot for me with visitors. Best, Don > On Dec 2, 2016, at 9:32 AM, Nowak, Martin A. <[email protected]> wrote: > Don , Jeffrey > I would like to put you in direct email contact. > also cc Lesley. >m please note The information contained in this =ommunication is confiden

er — under Bush II — was a partial PhD student =f mine when he was getting his MD at Harvard and his PhD in Econ at =IT, and remains a good friend: Mark McClellen, who is interested in =his stuff and remains quite influential in DC, I think). =nbsp; But the =eason for rambling about the FDA and placebo effects

From: jeffrey E. <[email protected]> Sent: Wednesday, December 7, 2016 5:48 PM To: Donald Rubin Subject: Re: Placebo effects, EB, etc. i might come up again,

: I'm always interested in unique idea On Wed, Dec 7, 2016 at 10:=2 AM Donald Rubin could be arranged either here or there. wrote: </=iv> Hello Jeffrey, I'm glad that Martin has put us in touch for a co=ple of reasons. First, I think we have some mutual interests concern=ng the complications of doi

ner — under Bush II — was a pa=tial PhD student of mine when he was getting his MD at Harvard and his PhD=in Econ at MIT, and remains a good friend: Mark McClellen, who is interest=d in this stuff and remains quite influential in DC, I think). But the reason for ra=bling about the FDA and placebo effects is th

From: jeffrey E. <[email protected]> Sent: Wednesday, December 7, 2016 5:53 PM To: Donald Rubin Subject: Re: Placebo effects, EB, etc. query, why are so many

Donald Rubi e: Great, thanks Martin= Sometime when I get to NYC, which I often do to visit Columbia conn=ctions, I'd like to be in touch, and give Jeffery more lectures in=statistics — I think he has some potential! <=r class="m_6900164931154966066m_-6698346136610420412m_- 11968057888153736=2gmail_msg

2401, under Bush II — was a partial PhD student of mine when he=was getting his MD at Harvard and his PhD in Econ at MIT, and remains a go=d friend: Mark McClellen, who is interested in this stuff and remains quit= influential in DC, I think). But the reason for rambling about the FDA and placebo eff=cts is th

From: jeffrey E. <[email protected]> Sent: Wednesday, December 7, 2016 3:39 PM To: Donald Rubin Subject: Re: Placebo effects, EB, etc. three way skype for 3.

com» wrote: I'm always int=rested in unique idea =n Wed, Dec 7, 2016 at 10:12 AM Donald Rubin <[email protected] <mailto:dbrubin@=e.com> wrote: Hello Jeffrey, I'm glad that Martin has put u= in touch for a couple of reasons. First, I think we have some mutua= interests concerning the complications of doi

Q=80Q under Bush II — was a partial PhD student of mine when he wa= getting his MD at Harvard and his PhD in Econ at MIT, and remains a good =riend: Mark McClellen, who is interested in this stuff and remains quite i=fluential in DC, I think). EFTA_R1_01919122 EFTA02667398 But the reason for rambling about